Tangmaikang Granules
Function and Efficacy
The drug has a certain inhibitory effect on the increase of blood sugar in rats caused by glucose, and has a significant effect on reducing the hyperglycemia of rats caused by alloxan and adrenaline; the drug can also significantly reduce the increase of plasma viscosity, reduced viscosity, red blood cell aggregation index and red blood cell rigidity index in diabetic rats caused by alloxan, and can reduce serum triglycerides and cholesterol in hyperlipidemia mice, among which the reduction of cholesterol is particularly significant. Swimming tests show that the drug can significantly improve the endurance and stress resistance of mice and prolong the swimming time.
Ingredients
The main ingredients are astragalus, rehmannia root, red peony root, salvia miltiorrhiza, Achyranthes bidentata, Ophiopogon japonicus, Polygonatum sibiricum, etc.
Appearance
This product is yellow-brown to brown-brown granules with a slight fragrance and a slightly bitter taste.
Usage and Dosage
Oral administration: 1 bag at a time, 3 times a day.
Adverse Reactions
No toxic side effects were observed in clinical practice.
Precautions
Not yet clear.
Special Population Medication
Precautions during pregnancy and lactation: Pregnant women should take with caution or follow doctor's advice.
Drug Interactions
The drug has a certain inhibitory effect on the increase in blood sugar in rats induced by glucose, and has a significant reducing effect on the hyperglycemia in rats induced by alloxan and adrenaline; the drug can also significantly reduce the increase in plasma viscosity, reduced viscosity, red blood cell aggregation index and red blood cell rigidity index in diabetic rats induced by alloxan, and can reduce serum triglycerides and cholesterol in hyperlipidemia mice. Swimming tests show that the drug can significantly improve the endurance and stress resistance of mice and prolong the swimming time.
Storage
Sealed.
Packaging Specification
5g per bag
Validity Period
24 months
Manufacturer
Chengdu Beite Denuo Pharmaceutical Co., Ltd.
-
Founded in:
2018-01-30 -
Address:
No. 66, Kelin Road West Section, Chengdu Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu -
Tax NO.:
91510115MA6CA1BY4U -
Registered Funds:
182.776863 yuan -
Email: